AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 159 filers reported holding AMYLYX PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $41,040 | -98.4% | 21,600 | -84.3% | 0.00% | -100.0% |
Q3 2023 | $2,518,046 | -44.5% | 137,523 | -34.6% | 0.02% | -48.7% |
Q2 2023 | $4,538,004 | -45.7% | 210,385 | -26.2% | 0.04% | -51.2% |
Q1 2023 | $8,362,046 | +102.2% | 285,005 | +154.6% | 0.08% | +135.3% |
Q4 2022 | $4,135,592 | -54.9% | 111,924 | -65.6% | 0.03% | -55.8% |
Q3 2022 | $9,168,000 | – | 325,700 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alpha Wave Global, LP | 853,262 | $18,404,861 | 12.06% |
Stonepine Capital Management, LLC | 1,121,028 | $24,180,574 | 8.72% |
GREAT POINT PARTNERS LLC | 968,795 | $20,896,908 | 4.09% |
Ghost Tree Capital, LLC | 550,000 | $11,863,500 | 3.92% |
Perceptive Advisors | 4,873,919 | $105,130,433 | 3.04% |
Altium Capital Management LP | 185,000 | $3,990,450 | 3.02% |
Boxer Capital, LLC | 2,084,000 | $44,952 | 2.08% |
SECTORAL ASSET MANAGEMENT INC | 387,310 | $8,354,277 | 1.39% |
AlphaCentric Advisors LLC | 108,000 | $2,329,560 | 1.29% |
EMERALD MUTUAL FUND ADVISERS TRUST | 680,035 | $14,668,355 | 0.80% |